Atlas Trials

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Clinical trial NCT05702905 · UNKNOWN

Trial details

NCT number
NCT05702905
Sponsor
Peking University First Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
PCOS (Polycystic Ovary Syndrome)Semaglutide
Start date
2023-05-09
Primary completion
2024-12-31
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.